James Whyte Black
Source: Web (npg.org.uk)
Sciences & Discovery • Historical Archive • 🇬🇧 Great Britain • 11 views

James Whyte Black 🇬🇧

James Whyte Black
Pharmacologist, Nobel Laureate, Drug Design Pioneer
Born Jun 14, 1924 🇬🇧 Uddingston, Great Britain
Passed Away Mar 22, 2010 London, United Kingdom
Lifespan 85 years old
11 views
Notice / Correction
"The most fruitful basis for the discovery of a new drug is to start with an old drug."

Archival Overview

Scottish pharmacologist who developed propranolol (the first beta-blocker) and cimetidine (the first H2 receptor antagonist), winning the 1988 Nobel Prize.

Biographical Record

Sir James Whyte Black studied medicine at the University of St Andrews. Driven by the death of his father from a heart attack, Black sought rational pharmacological approaches to reduce cardiac stress by blocking receptors rather than directly stimulating organs.

While working at ICI Pharmaceuticals, he invented propranolol in 1964, which became the world's most widely prescribed heart medication for angina and hypertension. Moving to Smith, Kline & French, he created cimetidine in 1972 to block histamine receptors in the stomach, creating the first effective treatment for peptic ulcers without surgery.

Key Life Milestones

1964

Development of Propranolol

Created the first clinically successful beta-blocker, transforming cardiology and saving countless patients from angina and myocardial infarction.

1988

Nobel Prize in Physiology or Medicine

Awarded the Nobel Prize alongside Gertrude Elion and George Hitchings for establishing fundamental principles of rational drug design.

Memorial Guestbook & Tributes

0 messages recorded

Leave a Respectful Tribute

No tributes recorded yet. Be the first to leave a message in honor of James Whyte Black.

Final Resting Place

Perpetual Memorial
Cremated, private memorial
London, United Kingdom
GPS: 51.5074, -0.1278
View on Memory Atlas
Archival Standards PastLegacies adheres to strict neutral biographical guidelines and legal standards of remembrance. Next-of-kin may request modifications or removal at any time via our expedited process.